Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Hafner

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|December 27, 2016
Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationLakshmi Jayashankar, Richard Hafner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesRobert N Mahon, Richard Hafner
Frontiers in Immunology|July 15, 2017
Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious DiseasesRobert N Mahon, Richard Hafner
Nature Reviews. Immunology|March 14, 2015
Advancing host-directed therapy for tuberculosisRobert S Wallis, Richard Hafner
The Journal of Infectious Diseases|March 27, 2012
Viewpoint: Challenges and opportunities in tuberculosis researchPeter S Kim, Mamodikoe Makhene, Christine Sizemore, et al.
Nature Reviews. Drug Discovery|March 2, 2012
Advancing the development of tuberculosis therapyAlimuddin Zumla, Richard Hafner, Christian Lienhardt, et al.
The New England Journal of Medicine|February 22, 2013
TuberculosisAlimuddin Zumla, Mario Raviglione, Richard Hafner, et al.
AIDS Research and Treatment|July 26, 2012
TB and HIV Therapeutics: Pharmacology Research PrioritiesKelly E Dooley, Peter S Kim, Sharon D Williams, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 22, 2018
Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and researchJing Bao, Richard Hafner, Yan Lin, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDSL Joseph Wheat, Patricia Connolly, Nicholas Haddad, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|December 27, 2016
Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationLakshmi Jayashankar, Richard Hafner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesRobert N Mahon, Richard Hafner
Frontiers in Immunology|July 15, 2017
Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious DiseasesRobert N Mahon, Richard Hafner
Nature Reviews. Immunology|March 14, 2015
Advancing host-directed therapy for tuberculosisRobert S Wallis, Richard Hafner
The Journal of Infectious Diseases|March 27, 2012
Viewpoint: Challenges and opportunities in tuberculosis researchPeter S Kim, Mamodikoe Makhene, Christine Sizemore, et al.
Nature Reviews. Drug Discovery|March 2, 2012
Advancing the development of tuberculosis therapyAlimuddin Zumla, Richard Hafner, Christian Lienhardt, et al.
The New England Journal of Medicine|February 22, 2013
TuberculosisAlimuddin Zumla, Mario Raviglione, Richard Hafner, et al.
AIDS Research and Treatment|July 26, 2012
TB and HIV Therapeutics: Pharmacology Research PrioritiesKelly E Dooley, Peter S Kim, Sharon D Williams, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 22, 2018
Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and researchJing Bao, Richard Hafner, Yan Lin, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDSL Joseph Wheat, Patricia Connolly, Nicholas Haddad, et al.
Pageof 5